학술논문

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
Document Type
Article
Author
Yuen, Man-FungAsselah, TarikJacobson, Ira MBrunetto, Maurizia RossanaJanssen, Harry L ATakehara, TetsuoHou, Jin LinKakuda, Thomas NLambrecht, TomBeumont, MariaKalmeijer, RonaldGuinard-Azadian, CarineMayer, CristianaJezorwski, JohnVerbinnen, ThierryLenz, OliverShukla, UmeshBiermer, MichaelBourgeois, StefanVanwolleghem, ThomasNevens, FrederikHorsmans, YvesVan Vlierberghe, HansNastri, Ana CatharinaLacerda, MarcusRamji, AlnoorConway, BrianCoffin, CarlaJanssen, HarryFung, ScottShafran, StephenHou, Jin LinSperl, JanUrbanek, PetrPlisek, StanislavHejda, VaclavSamuel, DidierLacombe, KarineZoulim, FabienGuyader, DominiqueRaffi, FrancoisAsselah, TarikBourliere, MarcHilleret, Marie-NoelleWedemeyer, HeinerSchulze zur Wiesch, JulianSprinzl, Kathrinvan Boemmel, FlorianHilgard, GudrunSabranski, MichaelArasteh, KeikawusChan, Henry LYYuen, Man FungWong, Vincent WsBrunetto, Maurizia RossanaTaliani, GloriaAndreone, PietroLampertico, PietroKurosaki, MasayukiYatsuhashi, HiroshiFujiwara, KeiTakehara, TetsuoKawaoka, TomokazuAsahina, YasuhiroEnomoto, HirayukiYabushita, KazuhisaNotsumata, KazuoTakaguchi, KoichiKawabe, NaotoKato, NaoyaKoji, OgawaNamisaki, TadashiSuzuki, YoshiyukiYoon, Jung-HwanAhn, SangHoonLim, Young-SukPaik, Seung WoonKiew, Kuang KiatMohamed, RosmawatiTan, Soek SiamLee, Yeong YehHlebowicz, MariaBerak, HannaGasiorowski, JacekHalota, WaldemarJanczewska, EwaGeyvandova, NataliaMorozov, ViacheslavAndreeva, AllaGusev, DenisBessonova, ElenaOsipenko, MarinaRomanova, SvetlanaGankina, NataliaSagalova, OlgaStepanova, TatianaCrespo Garcia, JavierDiago, MoisesInmaculada, FernandezCalleja, Jose LuisForns, XavierButi, MariaTangkijvanich, PisitTanwandee, TawesakPiratvisuth, TeerhaLeerapun, ApinyaYilmaz, GurdalTabak, Ömer FehmiAkarca, Ulus SalihAkova, MuratIdilman, RamazanForton, DanielBell, DavidAgarwal, KoshKennedy, PatrickFelizarta, FrancoSulkowski, MarkNahass, RonaldRojter, SergioJacobson, IraKorenblat, KevinGitlin, Norman
Source
The Lancet Gastroenterology & Hepatology; September 2023, Vol. 8 Issue: 9 p790-802, 13p
Subject
Language
ISSN
24681253
Abstract
JNJ-73763989 (JNJ-3989), a small interfering RNA, targets all hepatitis B virus (HBV) RNAs, reducing all HBV proteins. JNJ-56136379 (JNJ-6379; also known as bersacapavir), a capsid assembly modulator, inhibits HBV replication. We aimed to evaluate the efficacy (ie, antiviral activity) and safety of these therapeutics in combination with nucleos(t)ide analogues in patients with chronic hepatitis B.